Thalys Medical Technology Group Inc.

Shanghai Stock Exchange 603716.SS

Thalys Medical Technology Group Inc. Operating Cash Flow for the year ending December 31, 2023: USD 17.73 M

Thalys Medical Technology Group Inc. Operating Cash Flow is USD 17.73 M for the year ending December 31, 2023, a 335.11% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Thalys Medical Technology Group Inc. Operating Cash Flow for the year ending December 31, 2022 was USD 4.08 M, a 119.39% change year over year.
Thalys Medical Technology Group Inc. Operating Cash Flow for the year ending December 31, 2021 was USD -21.01 M, a -1,479.38% change year over year.
Thalys Medical Technology Group Inc. Operating Cash Flow for the year ending December 31, 2020 was USD 1.52 M, a -88.70% change year over year.
Thalys Medical Technology Group Inc. Operating Cash Flow for the year ending December 31, 2019 was USD 13.49 M, a 245.33% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Shanghai Stock Exchange: 603716.SS

Thalys Medical Technology Group Inc.

CEO	Mr. Zheng Wang
IPO Date	Oct. 31, 2016
Location	China
Headquarters	1310 Jinshan Avenue
Employees	1,406
Sector	Health Care
Industries Pharmaceuticals Hospitals & Clinics

Description

Thalys Medical Technology Group Inc. engages in the medical intensive business and operation services in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.

Key trends

Past 5 years